When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
EBS - Emergent Bio awarded 10-year HHS contract for VIGIV in smallpox
Emergent Biosolutions Inc.
Emergent BioSolutions (NYSE:EBS) has received a contract award of ~$535M over 10 years for the continued supply of Vaccinia Immune Globulin Intravenous (VIGIV) into the U.S. Strategic National Stockpile (SNS) in support of smallpox preparedness.
More news on: Emergent BioSolutions Inc., Healthcare stocks news,